For weight management, they are available only through specialist services for people meeting specific BMI and comorbidity criteria under NICE guidance
semaglutide 2.4 mg (Wegovy) has demonstrated weight loss of 10-15% in clinical trials, while other GLP-1 medications and lower doses typically produce more modest results
This product is offered strictly for qualified laboratory and scientific research applications where permitted by law
Opposing effects on body weight: Prednisolone is well-known for causing weight gain through multiple mechanisms, including increased appetite, fluid retention, and redistribution of body fat (particularly to the face, neck, and trunk)
Maurten Additions exist to interrupt that pattern
Patients need to understand this isnt a simple substitution, notes Dr